Top Story of the Week - Breaking: CDC Warning on Multi-State Disease Outbreak & E-Cigarettes, Vaping

Total Views : 99
Zoom In Zoom Out Read Later Print

Update: as of today the number of cases has grown to over 450 serious cases in 33 states & 1 US territory, with 5 deaths reported.

Top Story 7/31-9/7:

Breaking: CDC Warning on Multi-State Disease Outbreak & E-Cigarettes, Vaping 

This is our story that ran on 8/31:

  • As of August 27, 2019, 215 possible cases of severe pulmonary disease associated with the use of electronic cigarette, or e-cigarette, products, have been reported by 25 states and additional pulmonary illnesses are under investigation.
  • These are preliminary case counts based on initial reports. A new standardized case definition was released by CDC on August 25, 2019. Additional reports of pulmonary illness are being investigated by states to determine whether those illnesses are related to e-cigarette product use. These numbers are likely to change over time.
  • The available evidence does not currently suggest that an infectious disease is the cause of the illnesses.
  • The investigation has not identified any specific substance or e-cigarette product that is linked to all cases. Many patients report using e-cigarette products with liquids that contain cannabinoid products, such as tetrahydrocannabinol (THC).
  • These investigations are ongoing. CDC will provide updates when more information is available.

August 30, 2019

CDC, several states, and federal partners are investigating a multistate outbreak of severe pulmonary disease associated with using e-cigarette products. The investigation is ongoing and has not identified a cause, but all reported cases have indicated use of e-cigarette products.

Based on reports from several states, patients have experienced respiratory symptoms (cough, shortness of breath, or chest pain), and some have also experienced gastrointestinal symptoms (nausea, vomiting, or diarrhea) or non-specific symptoms (fatigue, fever, or weight loss). Some patients have reported that their symptoms developed over a few days, while others have reported that their symptoms developed over several weeks. Some patients have reported gastrointestinal symptoms began before respiratory symptoms. Fever, elevated heart rate, and elevated white blood cell count have been reported, even though no infectious disease has been identified. Many patients sought medical care in ambulatory settings, sometimes over several visits, before they were admitted to the hospital.

Many patients have required medical treatment with supplemental oxygen. Some required assisted ventilation. Some patients have been treated with corticosteroids with demonstrated improvement. Evidence does not suggest an infectious disease is the cause of the severe pulmonary disease. Antibiotic therapy alone has not consistently been associated with clinical improvement.

Investigation of the Outbreak

CDC, FDA, state and local health departments, and other clinical and public health partners are investigating a multistate outbreak of severe pulmonary disease associated with e-cigarette product (devices, liquids, refill pods, and/or cartridges) use. This ongoing investigation seeks to identify the exposures, demographic, clinical, and laboratory features and behaviors of patients. All patients have reported e-cigarette product use. Some patients have reported using e-cigarettes containing cannabinoid products, such as THC. To date, the investigation has not identified any single substance or e-cigarette product that has been consistently associated with illness.

State health departments are working with FDA to enable collection of e-cigarette product specimens for testing at the U.S. FDA Forensic Chemistry Center.

Complete information, here:

 

https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html